Examples of 'panitumumab' in a sentence
Meaning of "panitumumab"
panitumumab (noun) - A drug used in cancer treatment, specifically for colorectal cancer
Show more definitions
- A human monoclonal antibody used in the treatment of some cancers.
How to use "panitumumab" in a sentence
Basic
Advanced
panitumumab
Panitumumab may only be available in some situations.
There was an increase in mortality in the panitumumab arm.
It is unknown whether panitumumab is excreted in human breast milk.
Panitumumab administered as a single agent exhibits nonlinear pharmacokinetics.
Do not combine cetuximab or panitumumab to chemotherapy containing capecitabine.
It contains the active substance panitumumab.
Cetuximab and panitumumab are examples of monoclonal antibody inhibitors.
These include cetuximab and panitumumab.
Panitumumab may impact the ability of a woman to become pregnant.
Examples include cetuximab and panitumumab.
Panitumumab does not seem to work in tumour cells that contain mutated KRAS.
Similar results have been observed with panitumumab subsequently.
Panitumumab does not seem to work in tumour cells that contain mutated RAS genes.
The antibody may be panitumumab.
Panitumumab was the first monoclonal antibody to demonstrate the use of KRAS as a predictive biomarker.
See also
Colourless solution that may contain visible amorphous panitumumab particles.
Panitumumab works by binding to the extracellular domain of the EGFR preventing its activation.
Vectibix is a cancer medicine that contains the active substance panitumumab.
This may be due to patients receiving panitumumab after progression among those randomized to BSC.
Pregnant or may be pregnant prior to starting Panitumumab.
Panitumumab is manufactured by Amgen and marketed as Vectibix.
Studies to evaluate the mutagenic and carcinogenic potential of panitumumab have not been performed.
Cetuximab and panitumumab can be combined with FOLFOX or FOLFIRI.
The active ingredient in Vectibix is panitumumab.
Panitumumab does not work in patients who have KRAS or NRAS mutations.
Brief introduction to RAS and its role in the panitumumab mechanism of action.
Because of this, panitumumab has a boxed warning cautioning patients.
Brief introduction to KRAS and its role in the panitumumab mechanism of action.
Not estimable in the panitumumab arm and not estimable in the non-panitumumab arm.
The antigen binding protein is preferably selected from the group consisting of Cetuximab or Panitumumab.
Because human IgG is secreted into human milk, panitumumab might also be secreted.
In a preferred embodiment the EGFR-targeted monoclonal antibody is cetuximab or panitumumab.
VectibixTM contains the medicinal ingredient panitumumab which is an, antineoplastic.
In certain embodiments, a specific binding agent to an EGFr polypeptide is panitumumab.
If you are allergic ( hypersensitive ) to panitumumab or any of the other ingredients of Vectibix.
Drugs that target EGFR are cetuximab and panitumumab.
No anti-tumour effects of panitumumab were observed in human tumour xenografts lacking EGFR expression.
In certain such embodiments, the antibody is panitumumab.
Panitumumab does not seem to work against tumour cells that contain mutated ( abnormal ) RAS genes.
In certain embodiments, the specific binding agent is panitumumab.
Panitumumab is produced in genetically engineered mammalian cells ( Chinese Hamster Ovary ).
In certain embodiments, an antineoplastic agent is panitumumab.
Therapies with Cetuximab and Panitumumab are already indicated only for patients with wild-type K-RAS.
The therapeutic antibody is for example, panitumumab or cetuximab.
Panitumumab has been associated with skin rash, fatigue, nausea, diarrhea, fever, and decreased magnesium levels.
In one embodiment, the antibody is panitumumab.
Panitumumab ( Vectibix ) is usually given alone.
In preferred embodiments, the therapeutic monoclonal antibody is panitumumab or cetuximab.
Panitumumab ( Vectibix ® ) is approved to treat some patients with metastatic colon cancer.
Specific examples of anti-EGFR antibodies include cetuximab and panitumumab.
